Kuros Biosciences USA entered into a five-year exclusive sales agency agreement with Medtronic spinal division.

Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: Biosurgery Market worth $16.0 ...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, Kuros Biosciences ( VTX:KURN) shareholders have done very well over the last year, with the share ...

Jan. 15, 2025 — Scientists have come up with a drug that is a potential candidate for tackling memory deficits in the early stages of the disease in rodents. ... New Innovative Local Treatment ...

From new studies and milestones, here are seven key updates in orthobiologics since Nov. 13. 1. Bioretec signed a distribution agreement to accelerate commercialization of the RemeOs trauma screw ...

Solid Biosciences stock opened at $3.68 on Wednesday. The stock’s fifty day moving average price is $4.92 and its two-hundred day moving average price is $6.62. The firm has a market cap of $147 ...

Quanterix Corp. agreed to acquire life sciences peer Akoya Biosciences Inc. in an all-stock deal, combining two companies that detect diseases at different stages of progression. Akoya investors ...

MIAMI--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE) (the “Company” or “Pulse Biosciences”), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation ...

MOUNT LAUREL, N.J., Jan. 9, 2025 /PRNewswire/ -- Applying a newly identified biophysical mechanism of enzyme activation, researchers at the longevity therapeutics division of the diversified ...

From new partnerships to acquisitions, here are four key developments from spine and orthopedic medtech companies since Jan. 1.

Kuros Biosciences products include MagnetOs Putty (shown here) and MagnetOs Granules. [Image courtesy of the company] Kuros Biosciences USA recently announced a strategic five-year, exclusive ...